Authors
Latest:
Moving up the marketing maturity curveGiven the profound changes in the pharmaceutical commercial model, sales and marketing must deliver integrated customer experiences across channels and adapt through real-time insights
Latest:
The Interoperability IllusionYour serialization systems aren’t as interoperable as you might think
Latest:
Training Executives for Marketing ComplianceConventional training of sales forces is being complemented by executive-level training for corporate compliance
Latest:
Industry should reinforce cargo security practices with TAPA participationUltimately, supply chain integrity should include both temperature control and security against theft or diversion
Latest:
Forecasting Returns When Patents ExpireOverestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
Latest:
The outcomes-based reimbursement environmentA changing role for hubs in collecting critical data, raising adherence
Latest:
A Rebate Double-Whammy: Exploring the Unintended ConsequencesThe GSK Flovent example highlights the consequences for patients and pharma of the decision to eliminate the Medicaid rebate cap.
Latest:
The Pharma Industry's Place in a Connected Health WorldNew technologies are creating a powerful link between patients and healthcare providers. This Connected Health World has implications for pharmaceutical business practices
Latest:
Biosimilars: why deep discounts may become the dominant paradigmEuropean experience to date indicates a changing perspective on biosimilar pricing
Latest:
The Patient-Level Approach to Studying HealthcareLongitudinal patient-level data answer pressing questions about patient safety, outcomes and medication acceptance
Latest:
Recapping the Sarepta Saga—And Implications for IndustryA timeline of key developments surrounding Sarepta Therapeutics' Duchenne muscular dystrophy drug Elevidys, and the potential future impacts for gene therapy regulation and market access.
Latest:
On-Demand Digital Printing Rewires Pharma PackagingDigital systems are changing the economics and functionality of scheduling and production of printed packaging
Latest:
After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit DrugsIndustry and FDA can—and must—do more to protect global pharmaceutical supply chains
Latest:
Understanding Class of Trade Concepts‘Class of Trade’ is a murky element of contracts and channel analytics that can have important legal implications
Latest:
Fortifying Vaccine Supply ChainsHow they embrace collaboration will be key to the battle against RSV.
Latest:
Reshaping Biotechnology's Financing Relay RaceThe current economic downturn may fuel the creation of new, more sustainable business models
Latest:
Make Adverse Events and Customer Complaints Part of a Holistic Quality Management SystemUsually associated with manufacturing or laboratory processes, quality systems can improve post-marketing compliance efforts
Latest:
Focusing pharma marketing on 'headroom'In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'
Latest:
A Process-Based Approach To Aggregate SpendA Process-Based Assessment (PBA) is the first step to analyzing reporting needs
Latest:
A growing preference for ready-to-administer vaccines: new guidelines, evidence, and trendsVaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations
Latest:
Regulatory Focus on Off-Label Promotion Is RisingWhile FDA guidance on appropriate medical communication has evolved, US Dept. of Justice attention the practice is intensifying
Latest:
Maintaining R&D Investments in the IRA EraHow data-driven insights can help pharma companies balance their revenue management and innovation strategies—including resource allocation, pricing, and market access.
Latest:
Big Pharma requires big help in protecting CRT productsAn inside look at selection and implementation of passive thermal protection
Latest:
With coupons, pharma is saying 'Let's make a deal' to consumersPharma marketers become adept at refining coupon and voucher programs, while technology options multiply. Meanwhile payer criticism mounts
Latest:
NCPDP Standards for Accurate Billing, Reimbursement and AccessThe National Council for Prescription Drug Programs’ (NCPDP) Billing Unit Standard (BUS) brings order to pharmaceutical transactions. Between it, the National Drug Code (NDC) and the Structured Product Label (SPL), all necessary commercial information about a product is known.
Latest:
Preparing the Market for a New Drug with an Effective 'Medical Affairs Launch'The Medical Affairs function can play a vital role in today’s product launch process
Latest:
Hybrid Hub Models for the Patient JourneyJosh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, outlines the recent shift in the patient services industry towards a hybrid hub model for in-house management and outsourced support.
